CellBox Labs – Organ-on-Chip Innovation for European Strategic Autonomy
12 pages · PDF · 22 August 2025 · Licensed single-user copy, watermarked to the buyer
€299 excl. VAT — EU VAT calculated at checkout (VAT ID accepted for reverse charge); invoice issued after payment
One click to Stripe — guest checkout, no account. Your download appears on the confirmation page and arrives by e-mail right after payment (link valid 72 hours, up to 5 downloads).
About this report
Cellbox Labs is pioneering a European organ-on-chip platform that replicates human tissues (e.g. gut, lung, pancreas) on microfluidic chips. These biomimetic devices integrate living cells in fluidic channels to recreate organ functions, offering a novel alternative to animal testing.
The technology’s key features—custom polymers for realistic physiological environments, integrated oxygen and pH sensors, and automated fluidic control—enable personalized drug and toxicity testing in vitro. By combining such hardware with AI-driven “digital twin” models, Cellbox Labs aims to produce rich predictive data for pharmaceuticals.
Key questions this report answers
- How does Cellbox Labs' organ-on-chip platform replicate human tissues (gut, lung, pancreas) using custom polymers, integrated oxygen/pH sensors and automated fluidic control?
- How does combining biomimetic chips with AI-driven digital twin models produce predictive drug and toxicity data?
- How does the technology fit European strategic autonomy and dual-use market strategy as an alternative to animal testing?
- What are Cellbox Labs' capability gaps, dependencies and strategic indicators?
Inside this report
- Executive Summary
- 1. Corporate Identity & Legal Structure
- 2. Strategic Business Profile
- 3. Technology Portfolio Mapping
- 4. Technology Readiness Assessment
- 5. European Strategic Program Participation
- 6. Academic & Research Origins
- 7. Dual-Use Applications & European Market Strategy
- 8. Strategic Partnerships & European Industrial Alliances
- 9. European Market Focus & Operational Domains
- 10. Intellectual Property & Innovation Assets
- 11. Leadership & Technical Expertise
- 12. Capability and Gap Analysis
- 13. Strategic Indicators & Innovation Metrics
Who it's for
Investors screening Cellbox Labs, competitors and partners assessing their position, and analysts who need a sourced, structured account of the entity and its technology.
Related reports
Methodology, format & delivery
DFM reports are built from primary and official sources — TED procurement notices, CORDIS and the EU Funding & Tenders Portal, EIB operations, the NATO Innovation Fund portfolio, SIPRI data, official budget documents and company disclosures — read together with the underlying legal texts. Sources are cited in the document; it reflects them as of its publication date (22 August 2025). You receive a 12-page PDF, watermarked to you on every page, delivered on the confirmation page and by e-mail immediately after checkout (personal link valid 72 hours, up to 5 downloads). Guest checkout, single-user licence — Terms of Sale.
Related on DFM
More Tactical reports · Military Medical Tech · Digital Twins · Free summary of this report · All reports
Prefer unlimited access?
Prefer unlimited access? Every report like this is included in the DFM Analysis subscription. See plans →